143 related articles for article (PubMed ID: 23991087)
1. Rapamycin resistant murine th9 cells have a stable in vivo phenotype and inhibit graft-versus-host reactivity.
Mangus CW; Massey PR; Fowler DH; Amarnath S
PLoS One; 2013; 8(8):e72305. PubMed ID: 23991087
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD.
Amarnath S; Flomerfelt FA; Costanzo CM; Foley JE; Mariotti J; Konecki DM; Gangopadhyay A; Eckhaus M; Wong S; Levine BL; June CH; Fowler DH
Autophagy; 2010 May; 6(4):523-41. PubMed ID: 20404486
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism.
Foley JE; Jung U; Miera A; Borenstein T; Mariotti J; Eckhaus M; Bierer BE; Fowler DH
J Immunol; 2005 Nov; 175(9):5732-43. PubMed ID: 16237064
[TBL] [Abstract][Full Text] [Related]
5. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
[TBL] [Abstract][Full Text] [Related]
6. Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment.
Schliesser U; Chopra M; Beilhack A; Appelt C; Vogel S; Schumann J; Panov I; Vogt K; Schlickeiser S; Olek S; Wood K; Brandt C; Volk HD; Sawitzki B
Eur J Immunol; 2013 Dec; 43(12):3291-305. PubMed ID: 23946112
[TBL] [Abstract][Full Text] [Related]
7. Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells.
Li Y; Guan X; Liu W; Chen HL; Truscott J; Beyatli S; Metwali A; Weiner GJ; Zavazava N; Blumberg RS; Urban JF; Blazar BR; Elliott DE; Ince MN
J Immunol; 2018 Nov; 201(10):2910-2922. PubMed ID: 30291167
[TBL] [Abstract][Full Text] [Related]
8. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype.
Sad S; Mosmann TR
J Immunol; 1994 Oct; 153(8):3514-22. PubMed ID: 7930573
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
[TBL] [Abstract][Full Text] [Related]
10. Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.
Fowler DH; Mossoba ME; Steinberg SM; Halverson DC; Stroncek D; Khuu HM; Hakim FT; Castiello L; Sabatino M; Leitman SF; Mariotti J; Gea-Banacloche JC; Sportes C; Hardy NM; Hickstein DD; Pavletic SZ; Rowley S; Goy A; Donato M; Korngold R; Pecora A; Levine BL; June CH; Gress RE; Bishop MR
Blood; 2013 Apr; 121(15):2864-74. PubMed ID: 23426943
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human Th9 differentiation by type I interferons and IL-21.
Wong MT; Ye JJ; Alonso MN; Landrigan A; Cheung RK; Engleman E; Utz PJ
Immunol Cell Biol; 2010 Aug; 88(6):624-31. PubMed ID: 20421880
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
Yang YG; Sergio JJ; Pearson DA; Szot GL; Shimizu A; Sykes M
Blood; 1997 Dec; 90(11):4651-60. PubMed ID: 9373279
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
[TBL] [Abstract][Full Text] [Related]
15. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
16. IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling.
Xue G; Jin G; Fang J; Lu Y
Nat Commun; 2019 Mar; 10(1):1376. PubMed ID: 30914642
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th2, Th9, and Th17 responses and increasing the Treg response in a murine model.
Gu ZW; Wang YX; Cao ZW
Oncotarget; 2017 Feb; 8(9):14314-14324. PubMed ID: 28187441
[TBL] [Abstract][Full Text] [Related]
18. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection.
Mariotti J; Foley J; Jung U; Borenstein T; Kantardzic N; Han S; Hanson JT; Wong E; Buxhoeveden N; Trepel JB; Fojo AT; Telford W; Fowler DH
J Immunol; 2008 Jan; 180(1):89-105. PubMed ID: 18097008
[TBL] [Abstract][Full Text] [Related]
20. Toll like Receptor 2 engagement on CD4
Karim AF; Reba SM; Li Q; Boom WH; Rojas RE
Eur J Immunol; 2017 Sep; 47(9):1513-1524. PubMed ID: 28665005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
